This finding suggests the possibility that pharmacologic augmentation of PLIN5 expression coupled with an additional stimulus might work synergistically to promote loss of adipose mass as a means to treat obesity. The gene discussed is PLIN5; the disease is obesity due to melanocortin 4 receptor deficiency.